Miracor touts first-in-man study of catheter for severe heart attacks

Austria's Miracor Medical Systems has safely implanted PISCO, the company's catheter designed to treat patients who have suffered severe heart attacks. The device is implanted after angioplasty and clears blockage to prevent heart failure and facilitate healing. The company is testing the tech on 40 patients in a safety and feasibility study and will soon launch a randomized clinical trial for the device, it said. Report

Suggested Articles

AI-based drug molecule designer XtalPi has secured a mammoth funding round totaling $318.8 million, from global banking and tech investors.

LabCorp has licensed a blood test from Genfit designed to identify patients with risky cases of the liver disease NASH.

Philips has launched a compact, single-use device for physically clearing potentially dangerous blood clots lodged in the arms and legs.